Literature DB >> 22049907

Dephosphorylation reactions with deferoxamine, a potential chemical nuclease.

Elisa S Orth1, Michelle Medeiros, Tiago Bortolotto, Hernán Terenzi, Anthony J Kirby, Faruk Nome.   

Abstract

We report a detailed kinetic and mechanistic study of the reaction of a widely used therapeutic agent, deferoxamine (DFO), which contains three nucleophilic hydroxamate groups, with the model phosphate diester bis-2,4-dinitrophenylphosphate BDNPP. We clarify the mechanism by detecting important phosphorylated intermediates in the model reaction and show that the mechanism can be extended to the reaction with DNA. The effectiveness of DFO in cleaving DNA was examined over a range of pH in the absence and presence of a biologically available metal (Zn(2+)). The results inform and complement ongoing studies involving DFO, which can act as a powerful nucleophile toward DNA and other targets susceptible to nucleophilic attack.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22049907     DOI: 10.1021/jo202074y

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease.

Authors:  David I Finkelstein; Jessica L Billings; Paul A Adlard; Scott Ayton; Amelia Sedjahtera; Colin L Masters; Simon Wilkins; David M Shackleford; Susan A Charman; Wojciech Bal; Izabela A Zawisza; Ewa Kurowska; Andrew L Gundlach; Sheri Ma; Ashley I Bush; Dominic J Hare; Philip A Doble; Simon Crawford; Elisabeth Cl Gautier; Jack Parsons; Penny Huggins; Kevin J Barnham; Robert A Cherny
Journal:  Acta Neuropathol Commun       Date:  2017-06-28       Impact factor: 7.801

2.  ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson's Disease.

Authors:  Shanti Diwakarla; Rachel M McQuade; Remy Constable; Olivia Artaiz; Enie Lei; Kevin J Barnham; Paul A Adlard; Robert A Cherny; Madeleine R Di Natale; Hongyi Wu; Xin-Yi Chai; Victoria A Lawson; David I Finkelstein; John B Furness
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.